The FDA has received 2,680 adverse event reports for dogs that name Cephalexin.
- 2,680 reports name Cephalexin in dogs, which is 0.3% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
- 39% are marked serious and 10% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
- 15% are complaints that the product did not work (38% across all dog reports).
- The clinical signs reported most are vomiting, emesis and lethargy.
- The FDA lists 1 approved animal drug application containing Cephalexin for dogs, the earliest approved in 2012.
- None of this is a rate. The FDA data does not record how many dogs were given Cephalexin, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All dog reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 1,045 | 39% | 29% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 270 | 10% | 5.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 400 | 15% | 38% |
| Seizurea seizure or convulsion is among the clinical signs | 148 | 5.5% | 4.4% |
| Not used per labelthe report says the product was not used the way its label directs | 1,019 | 38% | 21% |
Where on the body do the reported signs sit?
Not on the body: Whole body 16% How it was given 8.6% Did not work 4.4%
- Stomach and gut43%vomiting, emesis, diarrhoea, anorexia and 3 more
- Whole body16%lethargy, death by euthanasia, death, lethargy
- Blood and organ tests16%other abnormal test result, elevated alanine aminotransferase (alt), elevated serum alkaline phosphatase (sap), abnormal radiograph finding and 2 more
- How it was given8.6%overdose, accidental exposure
- Brain and nerves5.7%seizure, ataxia
- Did not work4.4%lack of efficacy
- Behaviour2.4%behavioural disorder
- Skin and coat2.3%pruritus
- Heart and breathing1.6%panting
Each figure is a share of sign mentions among the 25 signs reported most for Cephalexin in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Vomiting703 26%
- Emesis368 14%
- Lethargy356 13%
- Diarrhoea215 8.0%
- Other abnormal test result206 7.7%
- Overdose189 7.0%
- Lack of efficacy182 6.8%
- Anorexia173 6.5%
Reports received per year
Is it approved for dogs?
The FDA lists 1 approved animal drug application containing Cephalexin for dogs, the earliest approved in 2012.
| Product | Form | Approved for | First approved | FDA application |
|---|---|---|---|---|
| RilexineVirbac AH, Inc. | Chewable Tablets RX | Dog | 2012 | 141-326 |
From the FDA record for Rilexine: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For Oral Use in Dogs Only.
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. See Cephalexin in cats (89 reports). Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Famotidine in dogs2,644
- Fluoxetine in dogs2,588
- Levothyroxine in dogs3,014
- Metronidazole in dogs3,094
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.